NCT07256236 2026-03-30
SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer
Fujian Cancer Hospital
Phase 2 Recruiting
Clinical Trials
12 trialsNCT07055399 2025-09-11
NICE-CC
Fujian Cancer Hospital
Phase 2 Recruiting
NCT03101995 2025-05-28
Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease
National Institute of Cancerología
Phase 2 Recruiting
NCT06455072 2024-06-12
Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer
Fujian Cancer Hospital
Phase 2 Recruiting
NCT05910177 2024-03-06
Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin
Fujian Cancer Hospital
Phase 2 Recruiting
NCT06149767 2023-11-29
Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT04294836 2022-12-07
Curcumin in Advanced Cervical Cancer
Instituto Nacional de Cancerologia, Columbia
Phase 2 Withdrawn
NCT03546855 2018-06-06
Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.
Anhui Provincial Hospital
Phase 2 Unknown
NCT02562729 2016-10-14
Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer
Shanghai Gynecologic Oncology Group
Phase 2 Completed
NCT00430144 2012-04-26
Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine Cervix
National Cancer Center, Korea
Phase 2 Completed
NCT01117402 2010-05-05
Tomotherapy in Postsurgery Recurrent Carcinoma Cervix
Tata Memorial Hospital
Phase 2 Unknown
NCT00404326 2006-11-28
Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer
National Institute of Cancerología
Phase 2 Completed